Logo image of DHCNI

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Stock Fundamental Analysis

NASDAQ:DHCNI - Nasdaq - US25525P2065

14.65  +0.01 (+0.07%)

Fundamental Rating

2

Overall DHCNI gets a fundamental rating of 2 out of 10. We evaluated DHCNI against 129 industry peers in the Diversified REITs industry. DHCNI may be in some trouble as it scores bad on both profitability and health. DHCNI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DHCNI has reported negative net income.
In the past year DHCNI had a positive cash flow from operations.
In the past 5 years DHCNI reported 4 times negative net income.
In multiple years DHCNI reported negative operating cash flow during the last 5 years.
DHCNI Yearly Net Income VS EBIT VS OCF VS FCFDHCNI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M -600M

1.2 Ratios

DHCNI has a Return On Assets of -7.29%. This is amonst the worse of the industry: DHCNI underperforms 92.86% of its industry peers.
DHCNI's Return On Equity of -18.81% is on the low side compared to the rest of the industry. DHCNI is outperformed by 88.10% of its industry peers.
Industry RankSector Rank
ROA -7.29%
ROE -18.81%
ROIC N/A
ROA(3y)-1.01%
ROA(5y)-1.3%
ROE(3y)-2.2%
ROE(5y)-3.08%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNI Yearly ROA, ROE, ROICDHCNI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

DHCNI has a worse Gross Margin (17.10%) than 96.03% of its industry peers.
In the last couple of years the Gross Margin of DHCNI has declined.
DHCNI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.61%
GM growth 5Y-22.42%
DHCNI Yearly Profit, Operating, Gross MarginsDHCNI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DHCNI has more shares outstanding
DHCNI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DHCNI is higher compared to a year ago.
DHCNI Yearly Shares OutstandingDHCNI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
DHCNI Yearly Total Debt VS Total AssetsDHCNI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

DHCNI has an Altman-Z score of 0.26. This is a bad value and indicates that DHCNI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.26, DHCNI is not doing good in the industry: 70.63% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.44 is on the high side and indicates that DHCNI has dependencies on debt financing.
The Debt to Equity ratio of DHCNI (1.44) is worse than 60.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 0.26
ROIC/WACCN/A
WACC7.33%
DHCNI Yearly LT Debt VS Equity VS FCFDHCNI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

DHCNI has a Current Ratio of 5.85. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
DHCNI has a Current ratio of 5.85. This is amongst the best in the industry. DHCNI outperforms 95.24% of its industry peers.
A Quick Ratio of 5.85 indicates that DHCNI has no problem at all paying its short term obligations.
The Quick ratio of DHCNI (5.85) is better than 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 5.85
Quick Ratio 5.85
DHCNI Yearly Current Assets VS Current LiabilitesDHCNI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for DHCNI have decreased strongly by -47.23% in the last year.
Looking at the last year, DHCNI shows a small growth in Revenue. The Revenue has grown by 6.62% in the last year.
The Revenue has been growing slightly by 4.77% on average over the past years.
EPS 1Y (TTM)-47.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)6.62%
Revenue growth 3Y-4.75%
Revenue growth 5Y4.77%
Sales Q2Q%4.8%

3.2 Future

Based on estimates for the next years, DHCNI will show a small growth in Earnings Per Share. The EPS will grow by 5.26% on average per year.
The Revenue is expected to grow by 5.77% on average over the next years.
EPS Next Y-61.26%
EPS Next 2Y-0.46%
EPS Next 3Y5.26%
EPS Next 5YN/A
Revenue Next Year5.41%
Revenue Next 2Y4.93%
Revenue Next 3Y5.77%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DHCNI Yearly Revenue VS EstimatesDHCNI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
DHCNI Yearly EPS VS EstimatesDHCNI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DHCNI. In the last year negative earnings were reported.
Also next year DHCNI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNI Price Earnings VS Forward Price EarningsDHCNI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DHCNI indicates a rather expensive valuation: DHCNI more expensive than 93.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.45
DHCNI Per share dataDHCNI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.46%
EPS Next 3Y5.26%

More info and screens

2

5. Dividend

5.1 Amount

DHCNI has a Yearly Dividend Yield of 1.92%.
Compared to an average industry Dividend Yield of 18.51, DHCNI's dividend is way lower than its industry peers. On top of this 85.71% of the companies listed in the same industry pay a better dividend than DHCNI!
DHCNI's Dividend Yield is comparable with the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

The dividend of DHCNI decreases each year by -51.94%.
DHCNI has paid a dividend for less than 5 years, so there is no long track record yet.
DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-51.94%
Div Incr Years0
Div Non Decr Years3
DHCNI Yearly Dividends per shareDHCNI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of DHCNI are negative and hence is the payout ratio. DHCNI will probably not be able to sustain this dividend level.
DP-2.5%
EPS Next 2Y-0.46%
EPS Next 3Y5.26%
DHCNI Yearly Income VS Free CF VS DividendDHCNI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M -600M

More info and screens

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (1/21/2025, 8:00:02 PM)

14.65

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners74.05%
Inst Owner ChangeN/A
Ins Owners0.35%
Ins Owner ChangeN/A
Market Cap3.53B
Analysts48
Price Target23.62 (61.23%)
Short Float %0%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend0.04
Dividend Growth(5Y)-51.94%
DP-2.5%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)41.93%
Min EPS beat(2)-23.76%
Max EPS beat(2)107.62%
EPS beat(4)1
Avg EPS beat(4)-3.44%
Min EPS beat(4)-70.3%
Max EPS beat(4)107.62%
EPS beat(8)3
Avg EPS beat(8)9.18%
EPS beat(12)3
Avg EPS beat(12)-12.53%
EPS beat(16)5
Avg EPS beat(16)-7.46%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-2.43%
Max Revenue beat(2)-1.19%
Revenue beat(4)0
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)-0.84%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)3
Avg Revenue beat(12)-1.06%
Revenue beat(16)3
Avg Revenue beat(16)-1.67%
PT rev (1m)15.76%
PT rev (3m)28.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.83%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.39
P/FCF N/A
P/OCF 40.71
P/B 1.73
P/tB 1.73
EV/EBITDA 28.45
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.93
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)0.36
OCFY2.46%
SpS6.12
BVpS8.49
TBVpS8.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.29%
ROE -18.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.1%
FCFM N/A
ROA(3y)-1.01%
ROA(5y)-1.3%
ROE(3y)-2.2%
ROE(5y)-3.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.61%
GM growth 5Y-22.42%
F-Score6
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA 13.46
Cap/Depr 69.24%
Cap/Sales 13.64%
Interest Coverage N/A
Cash Conversion 39.68%
Profit Quality N/A
Current Ratio 5.85
Quick Ratio 5.85
Altman-Z 0.26
F-Score6
WACC7.33%
ROIC/WACCN/A
Cap/Depr(3y)107.73%
Cap/Depr(5y)97.46%
Cap/Sales(3y)20.76%
Cap/Sales(5y)20.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-61.26%
EPS Next 2Y-0.46%
EPS Next 3Y5.26%
EPS Next 5YN/A
Revenue 1Y (TTM)6.62%
Revenue growth 3Y-4.75%
Revenue growth 5Y4.77%
Sales Q2Q%4.8%
Revenue Next Year5.41%
Revenue Next 2Y4.93%
Revenue Next 3Y5.77%
Revenue Next 5YN/A
EBIT growth 1Y-20.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year378.31%
EBIT Next 3Y75.54%
EBIT Next 5YN/A
FCF growth 1Y74.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y199.71%
OCF growth 3Y-59.56%
OCF growth 5Y-51.55%